⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HIMS News
Hims & Hers Health, Inc.
Compounding Pharmacy Market worth $21.01 billion by 2031 - Exclusive Report by MarketsandMarkets™
prnewswire.com
BAX
HIMS
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law
globenewswire.com
HIMS
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
prnewswire.com
HIMS
INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - HIMS
globenewswire.com
HIMS
Pomerantz LLP Issues Reminder to Shareholders in Hims & Hers Health, Inc. of Class Action Filing – HIMS
accessnewswire.com
HIMS
Robbins LLP Reminds HIMS Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action
globenewswire.com
HIMS
HIMS INVESTOR ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - November 2, 2026 Deadline
prnewswire.com
HIMS
Hims & Hers Health (NYSE: HIMS) Faces Securities Fraud Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower
globenewswire.com
HIMS
Deadline Alert: Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
globenewswire.com
HIMS
Portnoy Law Firm Announces Class Action on Behalf of Hims & Hers Health, Inc. Investors
globenewswire.com
HIMS